General Annual Meeting (GAM)
Pierre Strijckmans Lecture
Chairs: Marc André & Ann Janssens
Introduction
Dimitri Breems, ZNA, Belgium
AML diagnosis and treatment
Bob Löwenberg, Erasmus University Medical Center, Rotterdam, the Netherlands
Special Lecture 2
Chairs: Nicole Straetmans & Cécile Boulanger
Autoimmune hemolytic anemia for the hematologist
Marc Michel, Hôpital Henri-Mondor Paris-Est Créteil, France
Oral Abstracts
Chairs: Dimitri Breems & Marc André
Julien Devreux, de Duve Institute Brussels, Belgium
Stef Meers, AZ Klina Brasschaat, Belgium
Koen Debackere, KU Leuven / UZ Leuven, Belgium
Marie-Christiane Vekemans, UC Louvain, Belgium
Siska Blomme, AZ-Sint Jan Brugge, Belgium
Wouter De Brouwer, UZ Brussel, Belgium
Special Lecture 1
Chairs: Anke Verlinden & Sophie Servais
Paradigm shifts in managing infections in high-risk hematology patients
Johan Maertens, UZ Leuven, Belgium
Satellite 1 – Astra Zeneca : Recent advances in the treatment of CLL: bringing the patient into the equation
Chair: Vanessa Van Hende
Treatment advances for CLL patients in Belgium during the last decades
Ann Janssens, UZ Leuven, Belgium
Making a shared treatment decision
Jennifer Brown, Dana-Farber Cancer Institute Boston, USA
Elke Stienissen (LVV, BHS patient committee): video testimonial
Q&A
Joint BeSHG-BHS Meeting
Chairs: Helena Devos & Cécile Boulanger
How to detect predisposition: technique, type of tissue, turn around time
Carlijn Brekelmans, UZ Leuven, Belgium
Predisposition in lymphoid malignancies
Esme Waanders, Princes Maxima Center Utrecht, the Netherlands
Advances in Laboratory Technology
Chairs: Ivan Van Riet & Helena Devos
CHIP, CHOP, ARCH: lost in translation
Ann De Becker, UZ Brussel, Belgium
Genetic predisposition in myeloid malignancies
Ine Moors, UZ Gent, Belgium
Highlight 1
Chairs: Timothy Devos & Dominiek Mazure
Management of myelofibrosis: novel approaches and recent evolutions
Jean-Jaques Kiladjian, Hôpital Saint Louis Paris, France